|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 14,324.00 GBX | +2.26% |
|
+0.84% | +4.02% |
| 12:07pm | Hutchmed China hails lung cancer trial results published in Lancet | AN |
| 11:58am | Miners lift FTSE 100 ahead of US PPI | AN |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5d. change | Varia. Jan 1. | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| ASTRAZENECA PLC | Other Pharmaceuticals | +2.37% | +0.84% | +4.02% | +34.94% | +89.76% | 292B |  | | |
Technical Rankings Surperformance
- Stock Market
- Equities
- AZN Stock
- Charts AstraZeneca PLC
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition